Authors:
Rosa, JC
Galanakis, D
Piergentili, A
Bhandari, K
Ganellin, CR
Dunn, PM
Jenkinson, DH
Citation: Jc. Rosa et al., Synthesis, molecular modeling, and pharmacological testing of bis-quinolinium cyclophanes: Potent, non-peptidic blockers of the apamin-sensitive Ca2+-activated K+ channel, J MED CHEM, 43(3), 2000, pp. 420-431
Authors:
Tayebati, SK
Piergentili, A
Natale, D
Amenta, F
Citation: Sk. Tayebati et al., Evaluation of an agonist index: affinity ratio for compounds active on muscarinic cholinergic M-2 receptors, J AUT PHARM, 19(2), 1999, pp. 77-84
Authors:
Quaglia, W
Bousquet, P
Pigini, M
Carotti, A
Carrieri, A
Dontenwill, M
Gentili, F
Giannella, M
Maranca, F
Piergentili, A
Brasili, L
Citation: W. Quaglia et al., 2-(2-phenylcyclopropyl) imidazolines: Reversed enantioselective interaction at I-1 and I-2 imidazoline receptors, J MED CHEM, 42(15), 1999, pp. 2737-2740
Authors:
Quaglia, W
Pigini, M
Piergentili, A
Giannella, M
Marucci, G
Poggesi, E
Leonardi, A
Melchiorre, C
Citation: W. Quaglia et al., Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes, J MED CHEM, 42(15), 1999, pp. 2961-2968
Authors:
Pigini, M
Bousquet, P
Brasili, L
Carrieri, A
Cavagna, R
Dontenwill, M
Gentili, F
Giannella, M
Leonetti, F
Piergentili, A
Quaglia, W
Carotti, A
Citation: M. Pigini et al., Ligand binding to I-2 imidazoline receptor: The role of lipophilicity in quantitative structure-activity relationship models, BIO MED CH, 6(12), 1998, pp. 2245-2260